Ionis Pharmaceuticals Ownership 2024 | Who Owns Ionis Pharmaceuticals Now?
Institutional Ownership
10.24%
Insider Ownership
0.84%
Retail Ownership
88.92%
Institutional Holders
143.00
Ionis Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 15.04% | 0.07% | 21,894,806 | 32,071 | 0.15% | 1,043,506,454 | Jun 30, 2024 |
| VANGUARD GROUP INC | 9.51% | 0.01% | 13,845,712 | 415,256 | 3.09% | 659,886,634 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 8.68% | 0.38% | 12,639,684 | -677,428 | -5.09% | 602,408,000 | Jun 30, 2024 |
| BLACKROCK INC. | 7.09% | 0.01% | 10,321,030 | 549,139 | 5.62% | 491,900,289 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 5.68% | 6.40% | 8,260,434 | -39,080 | -0.47% | 393,692,284 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 4.51% | 0.06% | 6,568,808 | 873,109 | 15.33% | 313,069,390 | Jun 30, 2024 |
| STATE STREET CORP | 2.88% | 0.01% | 4,190,505 | 34,841 | 0.84% | 199,719,468,000 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.70% | 0.02% | 3,934,311 | 412,108 | 11.70% | 187,511,000 | Jun 30, 2024 |
| TWEEDY, BROWNE CO LLC | 2.37% | 7.57% | 3,454,676 | - | - | 164,649,858 | Jun 30, 2024 |
| BVF INC/IL | 2.19% | 4.26% | 3,186,376 | 757,763 | 31.20% | 151,862,680 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.71% | 0.01% | 2,484,544 | 120,288 | 5.09% | 118,445,256 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.66% | 0.13% | 2,409,954 | -1,329,803 | -35.56% | 114,858,408 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 1.63% | 2.25% | 2,372,333 | 359,300 | 17.85% | 113,065,391 | Jun 30, 2024 |
| CAPITAL WORLD INVESTORS | 1.55% | 0.02% | 2,252,089 | 1,412,626 | 168.28% | 107,334,562 | Jun 30, 2024 |
| CLEARBRIDGE INVESTMENTS, LLC | 1.48% | 0.08% | 2,160,270 | -2,305,921 | -51.63% | 102,958,447 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 1.37% | 2.85% | 2,000,000 | 626,525 | 45.62% | 95,320,000 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 1.29% | 0.10% | 1,873,668 | -1,326,910 | -41.46% | 89,299,000 | Jun 30, 2024 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 1.15% | 0.12% | 1,671,036 | 1,254,307 | 300.99% | 79,641,576 | Jun 30, 2024 |
| ARK INVESTMENT MANAGEMENT LLC | 0.94% | 0.58% | 1,361,025 | -38,827 | -2.77% | 64,866,465 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.91% | 0.01% | 1,328,106 | 26,738 | 2.05% | 63,297,524 | Jun 30, 2024 |
Ionis Pharmaceuticals's largest institutional shareholder is FMR LLC, holding 15.04% of the company's total share outstanding, currently valued at $1.04B. The top 10 institutional shareholders own together 60.67% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TWEEDY, BROWNE CO LLC | 2.37% | 7.57% | 3,454,676 | - | - | 164,649,858 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 5.68% | 6.40% | 8,260,434 | -39,080 | -0.47% | 393,692,284 | Jun 30, 2024 |
| BVF INC/IL | 2.19% | 4.26% | 3,186,376 | 757,763 | 31.20% | 151,862,680 | Jun 30, 2024 |
| 0.15% | 4.15% | 218,570 | 218,570 | 100.00% | 10,417,046 | Jun 30, 2024 | |
| SICART ASSOCIATES LLC | 0.13% | 3.50% | 191,523 | -2,470 | -1.27% | 9,127,986 | Jun 30, 2024 |
| SECTOR GAMMA AS | 0.12% | 3.03% | 170,000 | -5,507 | -3.14% | 8,102,200 | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | 0.23% | 3.01% | 330,000 | 330,000 | 100.00% | 15,727,800 | Jun 30, 2024 |
| PRIVIUM FUND MANAGEMENT B.V. | 0.17% | 2.85% | 247,267 | 20,274 | 8.93% | 11,161,632 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 1.37% | 2.85% | 2,000,000 | 626,525 | 45.62% | 95,320,000 | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | 0.11% | 2.30% | 160,166 | -129,200 | -44.65% | 7,633,512 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.34% | 2.26% | 500,000 | 500,000 | 100.00% | 23,830,000 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 1.63% | 2.25% | 2,372,333 | 359,300 | 17.85% | 113,065,391 | Jun 30, 2024 |
| TANAKA CAPITAL MANAGEMENT INC | 0.01% | 1.64% | 14,512 | -100 | -0.68% | 692,000 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.31% | 1.49% | 456,881 | 80,443 | 21.37% | 21,774,948 | Jun 30, 2024 |
| HEALTHINVEST PARTNERS AB | 0.03% | 1.18% | 40,691 | -23,100 | -36.21% | 1,939,333 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 0.21% | 1.16% | 300,000 | 300,000 | 100.00% | 14,298,000 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.17% | 1.13% | 250,000 | 250,000 | 100.00% | 11,915,000 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.11% | 1.03% | 161,705 | 20,206 | 14.28% | 7,706,860 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.10% | 0.91% | 140,238 | 140,238 | 100.00% | 6,683,743 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.10% | 0.73% | 150,000 | - | - | 7,149,000 | Jun 30, 2024 |
The largest Ionis Pharmaceuticals shareholder by % of total assets is TWEEDY, BROWNE CO LLC. The company owns 3.45M shares of Ionis Pharmaceuticals (IONS), representing 7.57% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CAPITAL WORLD INVESTORS | 1.55% | 0.02% | 2,252,089 | 1,412,626 | 168.28% | 107,334,562 | Jun 30, 2024 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 1.15% | 0.12% | 1,671,036 | 1,254,307 | 300.99% | 79,641,576 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.74% | 0.09% | 1,077,321 | 1,077,321 | 100.00% | 51,345,119 | Jun 30, 2024 |
| NORGES BANK | 0.70% | 0.01% | 1,019,341 | 1,019,341 | 100.00% | 48,581,792 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 4.51% | 0.06% | 6,568,808 | 873,109 | 15.33% | 313,069,390 | Jun 30, 2024 |
| BVF INC/IL | 2.19% | 4.26% | 3,186,376 | 757,763 | 31.20% | 151,862,680 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 1.37% | 2.85% | 2,000,000 | 626,525 | 45.62% | 95,320,000 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.50% | 0.22% | 723,618 | 552,758 | 323.52% | 34,487,633 | Jun 30, 2024 |
| BLACKROCK INC. | 7.09% | 0.01% | 10,321,030 | 549,139 | 5.62% | 491,900,289 | Jun 30, 2024 |
| INVESCO LTD. | 0.67% | 0.01% | 968,917 | 526,030 | 118.77% | 46,178,583 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.34% | 2.26% | 500,000 | 500,000 | 100.00% | 23,830,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 9.51% | 0.01% | 13,845,712 | 415,256 | 3.09% | 659,886,634 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.70% | 0.02% | 3,934,311 | 412,108 | 11.70% | 187,511,000 | Jun 30, 2024 |
| MAN GROUP PLC | 0.44% | 0.08% | 633,409 | 380,188 | 150.14% | 30,188,273 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 1.63% | 2.25% | 2,372,333 | 359,300 | 17.85% | 113,065,391 | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | 0.23% | 3.01% | 330,000 | 330,000 | 100.00% | 15,727,800 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.23% | 0.24% | 329,300 | 329,300 | 100.00% | 15,694,438 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 0.21% | 1.16% | 300,000 | 300,000 | 100.00% | 14,298,000 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.17% | 1.13% | 250,000 | 250,000 | 100.00% | 11,915,000 | Jun 30, 2024 |
| 0.15% | 4.15% | 218,570 | 218,570 | 100.00% | 10,417,046 | Jun 30, 2024 |
As of Jun 30 2024, Ionis Pharmaceuticals's largest institutional buyer is CAPITAL WORLD INVESTORS. The company purchased 1.41M stocks of IONS, valued at $107.33M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CLEARBRIDGE INVESTMENTS, LLC | 1.48% | 0.08% | 2,160,270 | -2,305,921 | -51.63% | 102,958,447 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.66% | 0.13% | 2,409,954 | -1,329,803 | -35.56% | 114,858,408 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 1.29% | 0.10% | 1,873,668 | -1,326,910 | -41.46% | 89,299,000 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 0.00% | 0.00% | 4,800 | -729,200 | -99.35% | 228,768 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 8.68% | 0.38% | 12,639,684 | -677,428 | -5.09% | 602,408,000 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.09% | 0.00% | 128,215 | -454,964 | -78.01% | 6,110,727 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | - | - | - | -421,487 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.30% | 0.03% | 436,818 | -308,355 | -41.38% | 20,818,746 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.02% | 0.00% | 24,226 | -247,037 | -91.07% | 1,154,611 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.02% | 0.01% | 35,311 | -242,480 | -87.29% | 1,682,904 | Jun 30, 2024 |
| LIONTRUST INVESTMENT PARTNERS LLP | 0.04% | 0.04% | 59,644 | -228,900 | -79.33% | 2,842,633 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.25% | 0.00% | 366,561 | -217,597 | -37.25% | 17,470,281 | Jun 30, 2024 |
| J. GOLDMAN & CO LP | 0.01% | 0.02% | 17,502 | -213,922 | -92.44% | 834,145 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.55% | 0.07% | 800,000 | -200,000 | -20.00% | 38,128,000 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | - | - | - | -191,367 | -100.00% | - | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.08% | 0.03% | 120,814 | -165,133 | -57.75% | 5,757,995 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.01% | 0.00% | 16,194 | -159,664 | -90.79% | 771,806 | Jun 30, 2024 |
| MORGAN STANLEY | 0.70% | 0.00% | 1,012,805 | -150,793 | -12.96% | 48,270,395 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.09% | 0.02% | 137,210 | -149,392 | -52.13% | 6,539,421 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.04% | 0.00% | 51,268 | -139,887 | -73.18% | 2,443,433 | Jun 30, 2024 |
As of Jun 30 2024, Ionis Pharmaceuticals's biggest institutional seller is CLEARBRIDGE INVESTMENTS, LLC. The company sold -2.31M shares of IONS, valued at $102.96M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | 0.74% | 0.09% | 1,077,321 | 1,077,321 | 100.00% | 51,345,119 | Jun 30, 2024 |
| NORGES BANK | 0.70% | 0.01% | 1,019,341 | 1,019,341 | 100.00% | 48,581,792 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.34% | 2.26% | 500,000 | 500,000 | 100.00% | 23,830,000 | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | 0.23% | 3.01% | 330,000 | 330,000 | 100.00% | 15,727,800 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.23% | 0.24% | 329,300 | 329,300 | 100.00% | 15,694,438 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 0.21% | 1.16% | 300,000 | 300,000 | 100.00% | 14,298,000 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.17% | 1.13% | 250,000 | 250,000 | 100.00% | 11,915,000 | Jun 30, 2024 |
| 0.15% | 4.15% | 218,570 | 218,570 | 100.00% | 10,417,046 | Jun 30, 2024 | |
| CAPTION MANAGEMENT, LLC | 0.11% | 0.12% | 160,000 | 160,000 | 100.00% | 7,625,600 | Jun 30, 2024 |
| J. GOLDMAN & CO LP | 0.10% | 0.20% | 145,000 | 145,000 | 100.00% | 6,910,700 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.10% | 0.91% | 140,238 | 140,238 | 100.00% | 6,683,743 | Jun 30, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 0.09% | 0.59% | 130,000 | 130,000 | 100.00% | 6,195,800 | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.07% | 0.04% | 105,000 | 105,000 | 100.00% | 5,004,300 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.06% | 0.07% | 90,000 | 90,000 | 100.00% | 4,289,400 | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | 0.04% | 0.58% | 62,479 | 62,479 | 100.00% | 2,977,749 | Jun 30, 2024 |
| GTS SECURITIES LLC | 0.04% | 0.01% | 60,930 | 60,930 | 100.00% | 2,903,924 | Jun 30, 2024 |
| BANK OF NOVA SCOTIA | 0.04% | 0.00% | 51,879 | 51,879 | 100.00% | 2,472,553 | Jun 30, 2024 |
| DRW SECURITIES, LLC | 0.04% | 0.10% | 50,956 | 50,956 | 100.00% | 2,428,562 | Jun 30, 2024 |
| DCF ADVISERS, LLC | 0.02% | 0.56% | 23,000 | 23,000 | 100.00% | 1,096,180 | Jun 30, 2024 |
| INCEPTIONR LLC | 0.01% | 0.23% | 17,289 | 17,289 | 100.00% | 823,994 | Jun 30, 2024 |
| EISLER CAPITAL (US) LLC | 0.01% | 0.01% | 16,270 | 16,270 | 100.00% | 775,428 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.01% | 0.06% | 13,430 | 13,430 | 100.00% | 640,074 | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | 0.01% | 0.00% | 13,098 | 13,098 | 100.00% | 624,251 | Jun 30, 2024 |
| STRATOS WEALTH PARTNERS, LTD. | 0.01% | 0.01% | 12,791 | 12,791 | 100.00% | 609,619 | Jun 30, 2024 |
| SPIDERROCK ADVISORS, LLC | 0.01% | 0.01% | 12,026 | 12,026 | 100.00% | 573,159 | Jun 30, 2024 |
| ANNIS GARDNER WHITING CAPITAL ADVISORS, LLC | 0.01% | 0.13% | 9,396 | 9,396 | 100.00% | 447,814 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.00% | 0.00% | 6,357 | 6,357 | 100.00% | 300,241 | Jun 30, 2024 |
| READYSTATE ASSET MANAGEMENT LP | 0.00% | 0.01% | 5,600 | 5,600 | 100.00% | 266,896 | Jun 30, 2024 |
| BRIDGEFRONT CAPITAL, LLC | 0.00% | 0.11% | 5,559 | 5,559 | 100.00% | 264,942 | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.00% | 0.00% | 5,326 | 5,326 | 100.00% | 252,239 | Jun 30, 2024 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 0.00% | 0.00% | 4,508 | 4,508 | 100.00% | 214,851 | Jun 30, 2024 |
| JONES FINANCIAL COMPANIES LLLP | 0.00% | 0.00% | 3,401 | 3,401 | 100.00% | 162,092 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.00% | 0.00% | 2,761 | 2,761 | 100.00% | 131,589 | Jun 30, 2024 |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.00% | 0.09% | 2,408 | 2,408 | 100.00% | 114,765 | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | 0.00% | 0.02% | 600 | 600 | 100.00% | 28,596 | Jun 30, 2024 |
| DCF ADVISERS, LLC | 0.00% | 0.01% | 500 | 500 | 100.00% | 23,830 | Jun 30, 2024 |
| ASHTON THOMAS PRIVATE WEALTH, LLC | 0.00% | 0.00% | 150 | 150 | 100.00% | 7,149 | Jun 30, 2024 |
| UNIQUE WEALTH STRATEGIES, LLC | 0.00% | 0.00% | 140 | 140 | 100.00% | 6,069 | Jun 30, 2024 |
| DUNHILL FINANCIAL, LLC | 0.00% | 0.00% | 130 | 130 | 100.00% | 6,196 | Jun 30, 2024 |
| FAMILY FIRM, INC. | 0.00% | 0.00% | 91 | 91 | 100.00% | 4,337 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | - | 0.00% | 59 | 59 | 100.00% | 2,786 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | - | 0.00% | 47 | 47 | 100.00% | 2,240 | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | - | - | 46 | 46 | 100.00% | 2,192 | Jun 30, 2024 |
| GREAT LAKES RETIREMENT, INC. | - | 0.00% | 43 | 43 | 100.00% | 2,049 | Jun 30, 2024 |
| TFC FINANCIAL MANAGEMENT, INC. | - | 0.00% | 21 | 21 | 100.00% | 1,001 | Jun 30, 2024 |
| THURSTON, SPRINGER, MILLER, HERD & TITAK, INC. | - | 0.00% | 20 | 20 | 100.00% | 953 | Jun 30, 2024 |
| LARSON FINANCIAL GROUP LLC | - | 0.00% | 18 | 18 | 100.00% | 858 | Jun 30, 2024 |
| PRINCIPAL SECURITIES, INC. | - | - | 13 | 13 | 100.00% | 620 | Jun 30, 2024 |
Ionis Pharmaceuticals's largest new institutional shareholder by number of shares is BALYASNY ASSET MANAGEMENT L.P., purchased 1.08M shares, valued at $51.35M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FIRST TURN MANAGEMENT, LLC | - | - | - | -421,487 | -100.00% | - | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | - | - | - | -191,367 | -100.00% | - | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -130,000 | -100.00% | - | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | - | - | - | -120,896 | -100.00% | - | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | - | - | - | -94,772 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -75,000 | -100.00% | - | Jun 30, 2024 |
| PARKWOOD LLC | - | - | - | -71,259 | -100.00% | - | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | - | - | - | -46,364 | -100.00% | - | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | - | - | - | -38,186 | -100.00% | - | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | - | - | - | -30,541 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -30,379 | -100.00% | - | Jun 30, 2024 |
| STRS OHIO | - | - | - | -29,965 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -25,000 | -100.00% | - | Jun 30, 2024 |
| EDGESTREAM PARTNERS, L.P. | - | - | - | -17,646 | -100.00% | - | Jun 30, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | - | - | - | -16,747 | -100.00% | - | Jun 30, 2024 |
| ENTROPY TECHNOLOGIES, LP | - | - | - | -14,542 | -100.00% | - | Jun 30, 2024 |
| BANK JULIUS BAER & CO. LTD, ZURICH | - | - | - | -14,230 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -12,000 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -11,800 | -100.00% | - | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | - | - | - | -11,700 | -100.00% | - | Jun 30, 2024 |
| CORTON CAPITAL INC. | - | - | - | -10,631 | -100.00% | - | Jun 30, 2024 |
| CAPULA MANAGEMENT LTD | - | - | - | -10,217 | -100.00% | - | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | - | - | - | -10,119 | -100.00% | - | Jun 30, 2024 |
| BARD FINANCIAL SERVICES, INC. | - | - | - | -9,950 | -100.00% | - | Jun 30, 2024 |
| WALLEYE TRADING LLC | - | - | - | -9,362 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -8,585 | -100.00% | - | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | - | - | - | -8,474 | -100.00% | - | Jun 30, 2024 |
| TORNO CAPITAL, LLC | - | - | - | -8,000 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -7,582 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -6,986 | -100.00% | - | Jun 30, 2024 |
| REGIONS FINANCIAL CORP | - | - | - | -6,785 | -100.00% | - | Jun 30, 2024 |
| BAIRD FINANCIAL GROUP, INC. | - | - | - | -6,696 | -100.00% | - | Jun 30, 2024 |
| WRAPMANAGER INC | - | - | - | -6,668 | -100.00% | - | Jun 30, 2024 |
| DIVERSIFIED TRUST CO | - | - | - | -6,015 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -5,891 | -100.00% | - | Jun 30, 2024 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | - | - | - | -5,580 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -5,500 | -100.00% | - | Jun 30, 2024 |
| TWIN TREE MANAGEMENT, LP | - | - | - | -5,200 | -100.00% | - | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | - | - | - | -4,909 | -100.00% | - | Jun 30, 2024 |
| VIDENT ADVISORY, LLC | - | - | - | -4,796 | -100.00% | - | Jun 30, 2024 |
| LEVEL FOUR ADVISORY SERVICES, LLC | - | - | - | -4,396 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -4,284 | -100.00% | - | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | - | - | - | -3,000 | -100.00% | - | Jun 30, 2024 |
| ICON WEALTH ADVISORS, LLC | - | - | - | -2,391 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -2,208 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -1,104 | -100.00% | - | Jun 30, 2024 |
| LIFESTEPS FINANCIAL, INC. | - | - | - | -200 | -100.00% | - | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | - | - | - | -82 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -76 | -100.00% | - | Jun 30, 2024 |
| CORNERSTONE PLANNING GROUP LLC | - | - | - | -45 | -100.00% | - | Jun 30, 2024 |
| CVA FAMILY OFFICE, LLC | - | - | - | -30 | -100.00% | - | Jun 30, 2024 |
| FIRST PACIFIC FINANCIAL | - | - | - | -29 | -100.00% | - | Jun 30, 2024 |
| CORECAP ADVISORS, LLC | - | - | - | -26 | -100.00% | - | Jun 30, 2024 |
| BOKF, NA | - | - | - | -7 | -100.00% | - | Jun 30, 2024 |
| ASSETMARK, INC | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
Ionis Pharmaceuticals's largest sold out institutional shareholder by shares sold is FIRST TURN MANAGEMENT, LLC, sold -0.42M shares, valued at -, as of undefined.
Ionis Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Virtus Convertible & Income 2024 Target Term Fund | 2.68% | 5,000,000 | - | - | Jan 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.84% | 981,000 | - | - | Mar 28, 2024 |
| ADVENT CONVERTIBLE & INCOME FUND | 0.74% | 2,522,000 | - | - | Jan 31, 2024 |
| ALGER FUNDS II | 0.67% | 152,463 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY GROWTH FUNDS, INC. | 0.66% | 102,081 | - | - | Jan 31, 2024 |
| Tema ETF Trust | 0.63% | 28,300 | 21,438 | 312.42% | Feb 29, 2024 |
| CALAMOS CONVERTIBLE & HIGH INCOME FUND | 0.52% | 6,450,000 | - | - | Jan 31, 2024 |
| CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND | 0.51% | 5,900,000 | - | - | Jan 31, 2024 |
| Delaware Enhanced Global Dividend & Income Fund | 0.50% | 182,000 | -180,000 | -49.72% | Feb 28, 2023 |
| DELAWARE INVESTMENTS DIVIDEND & INCOME FUND, INC | 0.44% | 116,000 | -35,000 | -23.18% | Feb 28, 2023 |
| Virtus Strategy Trust | 0.43% | 9,140,000 | - | - | Mar 28, 2024 |
| TWEEDY, BROWNE FUND INC. | 0.42% | 2,954,743 | - | - | Mar 28, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.39% | 11,312,657 | -154,787 | -1.35% | Feb 29, 2024 |
| TANAKA FUNDS INC | 0.33% | 7,500 | - | - | Feb 29, 2024 |
| Calamos Dynamic Convertible & Income Fund | 0.33% | 2,500,000 | - | - | Jan 31, 2024 |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 0.31% | 4,705,900 | -8,300 | -0.18% | Mar 31, 2024 |
| CALAMOS INVESTMENT TRUST/IL | 0.29% | 30,250,000 | - | - | Jan 31, 2024 |
| TOCQUEVILLE TRUST | 0.29% | 40,000 | - | - | Jan 31, 2024 |
| Virtus Equity & Convertible Income Fund | 0.25% | 490,000 | - | - | Jan 31, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.24% | 60,164 | 14,483 | 31.70% | Dec 31, 2023 |
| EntrepreneurShares Series Trust | 0.24% | 63,707 | - | - | Dec 31, 2023 |
| Virtus Dividend, Interest & Premium Strategy Fund | 0.24% | 565,000 | - | - | Jan 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.24% | 783,278 | -489,196 | -38.44% | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.23% | 1,146,309 | -123,282 | -9.71% | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.21% | 664,970 | 335 | 0.05% | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.20% | 744,500 | -1,000 | -0.13% | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.20% | 92,878 | 44,072 | 90.30% | Mar 31, 2024 |
| Virtus Diversified Income & Convertible Fund | 0.19% | 385,000 | - | - | Jan 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.18% | 215,677 | - | - | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.18% | 95,727 | - | - | Mar 31, 2024 |
| Ark ETF Trust | 0.18% | 1,471,354 | -580,534 | -28.29% | Jan 31, 2024 |
| PIONEER SERIES TRUST XII | 0.17% | 123,156 | 5,431 | 4.61% | Feb 29, 2024 |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. | 0.15% | 51,700 | - | - | Mar 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.15% | 126,543 | 38,930 | 44.43% | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.14% | 26,436 | 16,729 | 172.34% | Mar 28, 2024 |
| Virtus Convertible & Income Fund II | 0.13% | 490,000 | - | - | Jan 31, 2024 |
| Virtus Convertible & Income Fund | 0.13% | 620,000 | - | - | Jan 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.11% | 901,200 | -900 | -0.10% | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.11% | 1,360,598 | 807,194 | 145.86% | Jan 31, 2024 |
| Vanguard Montgomery Funds | 0.11% | 25,469 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.10% | 1,146,871 | -30,100 | -2.56% | Mar 31, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.10% | 3,000,000 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.08% | 817,379 | - | - | Mar 31, 2024 |
| FIDELITY FINANCIAL TRUST | 0.08% | 1,397,000 | - | - | Feb 29, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.08% | 126,225 | -22,155 | -14.93% | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.07% | 18,725 | -7,080 | -27.44% | Mar 31, 2024 |
| SARATOGA ADVANTAGE TRUST | 0.07% | 4,550 | - | - | Feb 29, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.07% | 8,329,000 | - | - | Mar 31, 2024 |
| MAINSTAY FUNDS | 0.06% | 14,497,000 | - | - | Jan 31, 2024 |
| BlackRock Health Sciences Trust II | 0.06% | 159,555 | -246,305 | -60.69% | Mar 31, 2024 |
| VANGUARD SPECIALIZED FUNDS | 0.06% | 3,063,073 | 1,416,950 | 86.08% | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.06% | 468,238 | - | - | Jan 31, 2024 |
| REYNOLDS FUNDS INC | 0.04% | 500 | - | - | Mar 31, 2024 |
| T. Rowe Price Tax-Efficient Funds, Inc. | 0.04% | 3,850 | - | - | Feb 29, 2024 |
| CORNERCAP GROUP OF FUNDS /VA/ | 0.04% | 2,806 | - | - | Sep 30, 2022 |
| Humankind Benefit Corp | 0.04% | 860 | -236 | -21.53% | Dec 31, 2023 |
| Nuveen S&P 500 Dynamic Overwrite Fund | 0.04% | 1,132 | - | - | Mar 31, 2024 |
| Nuveen Core Equity Alpha Fund | 0.04% | 2,632 | - | - | Mar 31, 2024 |
| AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS) | 0.04% | 1,240,416 | - | - | Jan 31, 2024 |
| Calvert Responsible Index Series, Inc. | 0.03% | 56,276 | - | - | Mar 31, 2024 |
| LEGG MASON PARTNERS INVESTMENT TRUST | 0.03% | 1,655,237 | -102,000 | -5.80% | Feb 29, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.03% | 125,525 | -121,802 | -49.25% | Jan 31, 2024 |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | 0.03% | 3,844 | - | - | Mar 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS V | 0.03% | 1,763,000 | - | - | Feb 29, 2024 |
| T. Rowe Price Mid-Cap Value Fund, Inc. | 0.03% | 315,030 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.03% | 11,060,571 | -2,848,793 | -20.48% | Mar 31, 2024 |
| Gateway Trust | 0.02% | 49,266 | - | - | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.02% | 498,826 | -207,022 | -29.33% | Mar 31, 2024 |
| HARBOR FUNDS | 0.02% | 449,000 | - | - | Jan 31, 2024 |
| ALGER FUNDS | 0.02% | 18,269 | - | - | Jan 31, 2024 |
| JNL VARIABLE FUND LLC | 0.02% | 97,056 | -2,760 | -2.77% | Mar 31, 2020 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 966,777 | - | - | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 3,279 | - | - | Mar 31, 2024 |
| LEGG MASON PARTNERS VARIABLE EQUITY TRUST | 0.01% | 58,098 | - | - | Dec 29, 2023 |
| DELAWARE VIP TRUST | 0.01% | 51,000 | -48,000 | -48.48% | Mar 28, 2024 |
| AIM EQUITY FUNDS (INVESCO EQUITY FUNDS) | 0.01% | 189,000 | - | - | Jan 31, 2024 |
| BLACKROCK ADVANTAGE GLOBAL FUND, INC. | 0.01% | 3,827 | 532 | 16.15% | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.01% | 30,000 | - | - | Mar 28, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.01% | 102,400 | - | - | Jan 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.01% | 839,463 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.01% | 3,638,000 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 37,414 | 589 | 1.60% | Feb 29, 2024 |
| John Hancock Exchange-Traded Fund Trust | 0.01% | 65,865 | 377 | 0.58% | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.01% | 43,310 | - | - | Mar 31, 2024 |
| Ivy Variable Insurance Portfolios | 0.01% | 231,201 | 24,052 | 11.61% | Mar 28, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.01% | 18,028 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.01% | 89,707 | - | - | Feb 29, 2024 |
| IVY FUNDS | 0.01% | 2,335,501 | 59,084 | 2.60% | Mar 28, 2024 |
| RYDEX SERIES FUNDS | 0.01% | 29,066 | -6,426 | -18.11% | Dec 31, 2023 |
| Legg Mason ETF Investment Trust | 0.01% | 13,275 | 277 | 2.13% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 1,348,928 | 44,350 | 3.40% | Feb 29, 2024 |
| Oaktree Diversified Income Fund Inc. | 0.01% | 21,000 | - | - | Mar 31, 2024 |
| LAZARD FUNDS INC | 0.01% | 244,000 | - | - | Mar 31, 2024 |
| TrimTabs ETF Trust | 0.01% | 3,790 | - | - | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 37,056 | - | - | Aug 31, 2023 |
| MSS Series Trust | 0.01% | 388 | - | - | Feb 29, 2024 |
| ETFis Series Trust I | 0.00% | 6,548 | -909 | -12.19% | Jan 31, 2024 |
| KINETICS PORTFOLIOS TRUST | 0.00% | 8,000 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust II | 0.00% | 4,704 | 12 | 0.26% | Feb 29, 2024 |
| ANCHOR SERIES TRUST | 0.00% | 132,896 | - | - | Sep 30, 2021 |
Ionis Pharmaceuticals's largest mutual fund holder by % of total assets is "Virtus Convertible & Income 2024 Target Term Fund", owning 5.00M shares, compromising 2.68% of its total assets.
Ionis Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 143 | -62.57% |
| 31 Mar, 24 | 382 | 0.26% |
| 31 Dec, 23 | 381 | 17.59% |
| 30 Sep, 23 | 324 | 3.51% |
| 30 Jun, 23 | 313 | -2.49% |
| 31 Mar, 23 | 321 | -6.96% |
| 31 Dec, 22 | 345 | -2.27% |
| 30 Sep, 22 | 353 | 0.57% |
| 30 Jun, 22 | 351 | 3.85% |
| 31 Mar, 22 | 338 | -3.98% |
| 31 Dec, 21 | 352 | 4.14% |
| 30 Sep, 21 | 338 | -3.70% |
| 30 Jun, 21 | 351 | -6.15% |
| 31 Mar, 21 | 374 | -5.32% |
| 31 Dec, 20 | 395 | 3.40% |
| 30 Sep, 20 | 382 | -2.05% |
| 30 Jun, 20 | 390 | 2.36% |
| 31 Mar, 20 | 381 | -6.85% |
| 31 Dec, 19 | 409 | 3.81% |
| 30 Sep, 19 | 394 | -6.41% |
| 30 Jun, 19 | 421 | -1.17% |
| 31 Mar, 19 | 426 | 21.02% |
| 31 Dec, 18 | 352 | 1.15% |
| 30 Sep, 18 | 348 | 6.10% |
| 30 Jun, 18 | 328 | -5.75% |
| 31 Mar, 18 | 348 | 2.35% |
| 31 Dec, 17 | 340 | 3.34% |
| 30 Sep, 17 | 329 | 5.11% |
| 30 Jun, 17 | 313 | 7.19% |
| 31 Mar, 17 | 292 | -12.57% |
| 31 Dec, 16 | 334 | 8.79% |
| 30 Sep, 16 | 307 | 0.66% |
| 30 Jun, 16 | 305 | -8.68% |
| 31 Mar, 16 | 334 | -8.49% |
| 31 Dec, 15 | 365 | - |
| 30 Jun, 10 | 1 | - |
As of 30 Jun 24, 143 institutions are holding Ionis Pharmaceuticals's shares, representing a decrease of -62.57% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 14,899,142 | -89.42% |
| 31 Mar, 24 | 140,874,193 | -0.89% |
| 31 Dec, 23 | 142,138,886 | 2.61% |
| 30 Sep, 23 | 138,518,212 | 2.98% |
| 30 Jun, 23 | 134,510,815 | 3.25% |
| 31 Mar, 23 | 130,276,734 | 0.61% |
| 31 Dec, 22 | 129,490,169 | 3.52% |
| 30 Sep, 22 | 125,091,627 | 1.28% |
| 30 Jun, 22 | 123,507,733 | -0.24% |
| 31 Mar, 22 | 123,810,437 | 0.94% |
| 31 Dec, 21 | 122,660,410 | 1.81% |
| 30 Sep, 21 | 120,477,981 | -2.11% |
| 30 Jun, 21 | 123,073,360 | 0.70% |
| 31 Mar, 21 | 122,218,371 | 1.82% |
| 31 Dec, 20 | 120,029,488 | 1.39% |
| 30 Sep, 20 | 118,383,693 | -1.38% |
| 30 Jun, 20 | 120,040,895 | 1.57% |
| 31 Mar, 20 | 118,181,727 | -2.04% |
| 31 Dec, 19 | 120,648,316 | -1.01% |
| 30 Sep, 19 | 121,874,439 | -3.68% |
| 30 Jun, 19 | 126,534,706 | 7.86% |
| 31 Mar, 19 | 117,312,329 | -0.36% |
| 31 Dec, 18 | 117,735,534 | -0.63% |
| 30 Sep, 18 | 118,487,221 | 0.17% |
| 30 Jun, 18 | 118,291,247 | 2.70% |
| 31 Mar, 18 | 115,184,560 | 1.26% |
| 31 Dec, 17 | 113,753,749 | -1.18% |
| 30 Sep, 17 | 115,112,989 | 3.05% |
| 30 Jun, 17 | 111,707,845 | 0.68% |
| 31 Mar, 17 | 110,949,038 | 2.11% |
| 31 Dec, 16 | 108,651,424 | 2.05% |
| 30 Sep, 16 | 106,471,417 | -2.56% |
| 30 Jun, 16 | 109,267,769 | 3.91% |
| 31 Mar, 16 | 105,151,165 | 1.82% |
| 31 Dec, 15 | 103,272,485 | - |
| 30 Jun, 10 | 1,000 | - |
Ionis Pharmaceuticals (IONS) has 14.90M shares outstanding as of 30 Jun 24, down -89.42% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 10.24% | 0.11% |
| 31 Mar, 24 | 98.38% | 1.00% |
| 31 Dec, 23 | 99.40% | 1.06% |
| 30 Sep, 23 | 96.80% | 1.09% |
| 30 Jun, 23 | 94.06% | 1.13% |
| 31 Mar, 23 | 91.10% | 1.09% |
| 31 Dec, 22 | 91.29% | 1.18% |
| 30 Sep, 22 | 88.12% | 1.16% |
| 30 Jun, 22 | 87.10% | 1.14% |
| 31 Mar, 22 | 87.44% | 1.16% |
| 31 Dec, 21 | 86.98% | 1.19% |
| 30 Sep, 21 | 85.36% | 1.12% |
| 30 Jun, 21 | 87.31% | 1.16% |
| 31 Mar, 21 | 86.82% | 1.17% |
| 31 Dec, 20 | 85.97% | 1.20% |
| 30 Sep, 20 | 84.74% | 1.14% |
| 30 Jun, 20 | 86.14% | 1.20% |
| 31 Mar, 20 | 84.76% | 1.16% |
| 31 Dec, 19 | 85.57% | 1.14% |
| 30 Sep, 19 | 86.71% | 1.06% |
| 30 Jun, 19 | 90.38% | 1.26% |
| 31 Mar, 19 | 84.65% | 1.07% |
| 31 Dec, 18 | 88.98% | 1.30% |
| 30 Sep, 18 | 82.68% | 0.98% |
| 30 Jun, 18 | 91.90% | 1.09% |
| 31 Mar, 18 | 91.91% | 1.09% |
| 31 Dec, 17 | 91.73% | 1.07% |
| 30 Sep, 17 | 92.56% | 1.14% |
| 30 Jun, 17 | 90.10% | 1.10% |
| 31 Mar, 17 | 90.30% | 1.12% |
| 31 Dec, 16 | 89.84% | 1.16% |
| 30 Sep, 16 | 88.00% | 1.08% |
| 30 Jun, 16 | 90.45% | 1.19% |
| 31 Mar, 16 | 87.19% | 1.17% |
| 31 Dec, 15 | 86.26% | - |
| 30 Jun, 10 | 0.00% | - |
As of 30 Jun 24, Ionis Pharmaceuticals is held by 10.24% institutional shareholders, representing a 0.11% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 63 | -62.72% |
| 31 Mar, 24 | 169 | -10.11% |
| 31 Dec, 23 | 188 | 38.24% |
| 30 Sep, 23 | 136 | 3.03% |
| 30 Jun, 23 | 132 | 3.94% |
| 31 Mar, 23 | 127 | -23.03% |
| 31 Dec, 22 | 165 | 10.74% |
| 30 Sep, 22 | 149 | 0.68% |
| 30 Jun, 22 | 148 | -3.27% |
| 31 Mar, 22 | 153 | -5.56% |
| 31 Dec, 21 | 162 | 16.55% |
| 30 Sep, 21 | 139 | -13.13% |
| 30 Jun, 21 | 160 | -9.60% |
| 31 Mar, 21 | 177 | -8.29% |
| 31 Dec, 20 | 193 | 26.97% |
| 30 Sep, 20 | 152 | -8.98% |
| 30 Jun, 20 | 167 | 21.01% |
| 31 Mar, 20 | 138 | -23.33% |
| 31 Dec, 19 | 180 | 6.51% |
| 30 Sep, 19 | 169 | -25.88% |
| 30 Jun, 19 | 228 | 9.09% |
| 31 Mar, 19 | 209 | 50.36% |
| 31 Dec, 18 | 139 | 1.46% |
| 30 Sep, 18 | 137 | -1.44% |
| 30 Jun, 18 | 139 | -16.27% |
| 31 Mar, 18 | 166 | 19.42% |
| 31 Dec, 17 | 139 | -10.32% |
| 30 Sep, 17 | 155 | 10.71% |
| 30 Jun, 17 | 140 | 14.75% |
| 31 Mar, 17 | 122 | -22.29% |
| 31 Dec, 16 | 157 | 38.94% |
| 30 Sep, 16 | 113 | -25.66% |
| 30 Jun, 16 | 152 | -9.52% |
| 31 Mar, 16 | 168 | -49.55% |
| 31 Dec, 15 | 333 | - |
| 30 Jun, 10 | 1 | - |
63 institutional shareholders have increased their position in IONS stock as of 30 Jun 24 compared to 169 in the previous quarter (a -62.72% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 53 | -57.60% |
| 31 Mar, 24 | 125 | 5.04% |
| 31 Dec, 23 | 119 | 10.19% |
| 30 Sep, 23 | 108 | -0.92% |
| 30 Jun, 23 | 109 | -9.92% |
| 31 Mar, 23 | 121 | 14.15% |
| 31 Dec, 22 | 106 | -18.46% |
| 30 Sep, 22 | 130 | 6.56% |
| 30 Jun, 22 | 122 | 9.91% |
| 31 Mar, 22 | 111 | -4.31% |
| 31 Dec, 21 | 116 | 10.48% |
| 30 Sep, 21 | 105 | -1.87% |
| 30 Jun, 21 | 107 | -4.46% |
| 31 Mar, 21 | 112 | 7.69% |
| 31 Dec, 20 | 104 | -19.38% |
| 30 Sep, 20 | 129 | -2.27% |
| 30 Jun, 20 | 132 | -5.04% |
| 31 Mar, 20 | 139 | 6.92% |
| 31 Dec, 19 | 130 | 9.24% |
| 30 Sep, 19 | 119 | 20.20% |
| 30 Jun, 19 | 99 | -22.66% |
| 31 Mar, 19 | 128 | 10.34% |
| 31 Dec, 18 | 116 | 3.57% |
| 30 Sep, 18 | 112 | 24.44% |
| 30 Jun, 18 | 90 | -15.89% |
| 31 Mar, 18 | 107 | -12.30% |
| 31 Dec, 17 | 122 | 35.56% |
| 30 Sep, 17 | 90 | -4.26% |
| 30 Jun, 17 | 94 | 1.08% |
| 31 Mar, 17 | 93 | -1.06% |
| 31 Dec, 16 | 94 | -21.67% |
| 30 Sep, 16 | 120 | 73.91% |
| 30 Jun, 16 | 69 | -17.86% |
| 31 Mar, 16 | 84 | - |
| 31 Dec, 15 | - | - |
| 30 Jun, 10 | - | - |
53 institutional shareholders have reduced their position in IONS stock as of 30 Jun 24 compared to 125 in the previous quarter (a -57.60% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 143 | -62.57% | 14,899,142 | -89.42% | 10.24% | 0.11% | 63 | -62.72% | 53 | -57.60% |
| 31 Mar, 24 | 382 | 0.26% | 140,874,193 | -0.89% | 98.38% | 1.00% | 169 | -10.11% | 125 | 5.04% |
| 31 Dec, 23 | 381 | 17.59% | 142,138,886 | 2.61% | 99.40% | 1.06% | 188 | 38.24% | 119 | 10.19% |
| 30 Sep, 23 | 324 | 3.51% | 138,518,212 | 2.98% | 96.80% | 1.09% | 136 | 3.03% | 108 | -0.92% |
| 30 Jun, 23 | 313 | -2.49% | 134,510,815 | 3.25% | 94.06% | 1.13% | 132 | 3.94% | 109 | -9.92% |
| 31 Mar, 23 | 321 | -6.96% | 130,276,734 | 0.61% | 91.10% | 1.09% | 127 | -23.03% | 121 | 14.15% |
| 31 Dec, 22 | 345 | -2.27% | 129,490,169 | 3.52% | 91.29% | 1.18% | 165 | 10.74% | 106 | -18.46% |
| 30 Sep, 22 | 353 | 0.57% | 125,091,627 | 1.28% | 88.12% | 1.16% | 149 | 0.68% | 130 | 6.56% |
| 30 Jun, 22 | 351 | 3.85% | 123,507,733 | -0.24% | 87.10% | 1.14% | 148 | -3.27% | 122 | 9.91% |
| 31 Mar, 22 | 338 | -3.98% | 123,810,437 | 0.94% | 87.44% | 1.16% | 153 | -5.56% | 111 | -4.31% |
| 31 Dec, 21 | 352 | 4.14% | 122,660,410 | 1.81% | 86.98% | 1.19% | 162 | 16.55% | 116 | 10.48% |
| 30 Sep, 21 | 338 | -3.70% | 120,477,981 | -2.11% | 85.36% | 1.12% | 139 | -13.13% | 105 | -1.87% |
| 30 Jun, 21 | 351 | -6.15% | 123,073,360 | 0.70% | 87.31% | 1.16% | 160 | -9.60% | 107 | -4.46% |
| 31 Mar, 21 | 374 | -5.32% | 122,218,371 | 1.82% | 86.82% | 1.17% | 177 | -8.29% | 112 | 7.69% |
| 31 Dec, 20 | 395 | 3.40% | 120,029,488 | 1.39% | 85.97% | 1.20% | 193 | 26.97% | 104 | -19.38% |
| 30 Sep, 20 | 382 | -2.05% | 118,383,693 | -1.38% | 84.74% | 1.14% | 152 | -8.98% | 129 | -2.27% |
| 30 Jun, 20 | 390 | 2.36% | 120,040,895 | 1.57% | 86.14% | 1.20% | 167 | 21.01% | 132 | -5.04% |
| 31 Mar, 20 | 381 | -6.85% | 118,181,727 | -2.04% | 84.76% | 1.16% | 138 | -23.33% | 139 | 6.92% |
| 31 Dec, 19 | 409 | 3.81% | 120,648,316 | -1.01% | 85.57% | 1.14% | 180 | 6.51% | 130 | 9.24% |
| 30 Sep, 19 | 394 | -6.41% | 121,874,439 | -3.68% | 86.71% | 1.06% | 169 | -25.88% | 119 | 20.20% |
| 30 Jun, 19 | 421 | -1.17% | 126,534,706 | 7.86% | 90.38% | 1.26% | 228 | 9.09% | 99 | -22.66% |
| 31 Mar, 19 | 426 | 21.02% | 117,312,329 | -0.36% | 84.65% | 1.07% | 209 | 50.36% | 128 | 10.34% |
| 31 Dec, 18 | 352 | 1.15% | 117,735,534 | -0.63% | 88.98% | 1.30% | 139 | 1.46% | 116 | 3.57% |
| 30 Sep, 18 | 348 | 6.10% | 118,487,221 | 0.17% | 82.68% | 0.98% | 137 | -1.44% | 112 | 24.44% |
| 30 Jun, 18 | 328 | -5.75% | 118,291,247 | 2.70% | 91.90% | 1.09% | 139 | -16.27% | 90 | -15.89% |
| 31 Mar, 18 | 348 | 2.35% | 115,184,560 | 1.26% | 91.91% | 1.09% | 166 | 19.42% | 107 | -12.30% |
| 31 Dec, 17 | 340 | 3.34% | 113,753,749 | -1.18% | 91.73% | 1.07% | 139 | -10.32% | 122 | 35.56% |
| 30 Sep, 17 | 329 | 5.11% | 115,112,989 | 3.05% | 92.56% | 1.14% | 155 | 10.71% | 90 | -4.26% |
| 30 Jun, 17 | 313 | 7.19% | 111,707,845 | 0.68% | 90.10% | 1.10% | 140 | 14.75% | 94 | 1.08% |
| 31 Mar, 17 | 292 | -12.57% | 110,949,038 | 2.11% | 90.30% | 1.12% | 122 | -22.29% | 93 | -1.06% |
| 31 Dec, 16 | 334 | 8.79% | 108,651,424 | 2.05% | 89.84% | 1.16% | 157 | 38.94% | 94 | -21.67% |
| 30 Sep, 16 | 307 | 0.66% | 106,471,417 | -2.56% | 88.00% | 1.08% | 113 | -25.66% | 120 | 73.91% |
| 30 Jun, 16 | 305 | -8.68% | 109,267,769 | 3.91% | 90.45% | 1.19% | 152 | -9.52% | 69 | -17.86% |
| 31 Mar, 16 | 334 | -8.49% | 105,151,165 | 1.82% | 87.19% | 1.17% | 168 | -49.55% | 84 | - |
| 31 Dec, 15 | 365 | - | 103,272,485 | - | 86.26% | - | 333 | - | - | - |
| 30 Jun, 10 | 1 | - | 1,000 | - | 0.00% | - | 1 | - | - | - |
Ionis Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Ionis Pharmaceuticals's stock was made by Geary Richard S on Aug 06 2024, selling 2,430 shares at $48.00 per share (valued at $116.64K).
Ionis Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 25 | 11 | 227.27% |
| Q2 2024 | 4 | 13 | 30.77% |
| Q1 2024 | 64 | 40 | 160.00% |
| Q4 2023 | 23 | 44 | 52.27% |
| Q3 2023 | 34 | 21 | 161.90% |
| Q2 2023 | 5 | 11 | 45.45% |
| Q1 2023 | 66 | 40 | 165.00% |
| Q4 2022 | 3 | 4 | 75.00% |
| Q3 2022 | 41 | 23 | 178.26% |
| Q2 2022 | 4 | 8 | 50.00% |
| Q1 2022 | 42 | 20 | 210.00% |
| Q4 2021 | 9 | 10 | 90.00% |
| Q3 2021 | 55 | 30 | 183.33% |
| Q2 2021 | 4 | 11 | 36.36% |
| Q1 2021 | 37 | 29 | 127.59% |
| Q4 2020 | 21 | 56 | 37.50% |
| Q3 2020 | 57 | 34 | 167.65% |
| Q2 2020 | 6 | 13 | 46.15% |
| Q1 2020 | 35 | 35 | 100.00% |
| Q4 2019 | 14 | 27 | 51.85% |
25 total buy trades, and 11 total sell trades (buy/sell ratio of 2.27%) were made by Ionis Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 4 | - |
| Q2 2024 | - | 9 | - |
| Q1 2024 | - | 25 | - |
| Q4 2023 | - | 21 | - |
| Q3 2023 | - | 6 | - |
| Q2 2023 | - | 6 | - |
| Q1 2023 | - | 20 | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | 4 | - |
| Q2 2022 | - | 3 | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | 1 | - |
| Q2 2021 | - | 4 | - |
| Q1 2021 | - | 8 | - |
| Q4 2020 | - | 24 | - |
| Q3 2020 | - | 3 | - |
| Q2 2020 | - | 8 | - |
| Q1 2020 | - | 15 | - |
| Q4 2019 | - | 12 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 4 open market sell trades of Ionis Pharmaceuticals's stocks.
Ionis Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| INCY | Incyte Corporation |
| ARWR | Arrowhead Pharmaceuticals, Inc. |
| AKRO | Akero Therapeutics, Inc. |
| PTCT | PTC Therapeutics, Inc. |
| IOVA | Iovance Biotherapeutics, Inc. |
| APLS | Apellis Pharmaceuticals, Inc. |
| HALO | Halozyme Therapeutics, Inc. |
| EXEL | Exelixis, Inc. |
| SRPT | Sarepta Therapeutics, Inc. |
| BMRN | BioMarin Pharmaceutical Inc. |
| ALNY | Alnylam Pharmaceuticals, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| VKTX | Viking Therapeutics, Inc. |
| KRYS | Krystal Biotech, Inc. |
| MDGL | Madrigal Pharmaceuticals, Inc. |
IONS Ownership FAQ
Who Owns Ionis Pharmaceuticals?
Ionis Pharmaceuticals is owned by institutional shareholders (10.24%), insiders (0.84%), and public (88.92%). The largest institutional shareholder of Ionis Pharmaceuticals is FMR LLC (15.04% of total shares) and the top mutual fund owner is Virtus Convertible & Income 2024 Target Term Fund (2.68% of total shares).
Who are the major institutional shareholders of Ionis Pharmaceuticals?
Ionis Pharmaceuticals's major institutional shareholders are FMR LLC, VANGUARD GROUP INC, T. ROWE PRICE INVESTMENT MANAGEMENT, INC., BLACKROCK INC., and BELLEVUE GROUP AG. The top five shareholders own together 46.01% of the company's share outstanding.
How many Ionis Pharmaceuticals shareholders are there?
As of Jun 2024, there are 143 institutional shareholders of Ionis Pharmaceuticals.
What percentage of Ionis Pharmaceuticals is owned by FMR LLC?
FMR LLC owns 21.89M shares of Ionis Pharmaceuticals, representing 15.04% of the company's total shares outstanding, valued at $1.04B (as of Jun 2024).
What percentage of Ionis Pharmaceuticals is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 13.85M shares of Ionis Pharmaceuticals (IONS), compromising 9.51% of the company, valued at $659.89M.
What percentage of Ionis Pharmaceuticals is owned by T. ROWE PRICE INVESTMENT MANAGEMENT, INC?
T. ROWE PRICE INVESTMENT MANAGEMENT, INC is the third largest holder of Ionis Pharmaceuticals. The company owns 12.64M of the company's shares outstanding (worth $602.41M).